Please provide your email address to receive an email when new articles are posted on . The FDA has already approved remibrutinib for chronic spontaneous urticaria. This phase 2 study demonstrates ...

This approach accepts that peanut exposure is unavoidable and seeks instead to neutralize the maladaptive IgE responses made to food allergens. This tactic is being evaluated in Phase I and Phase II ...

Ten years ago, public health experts recommended a radical shift in pediatric care. Children should not be shielded from common allergens like peanuts, they said, but exposed early to prevent eventual ...

A quiet but powerful process begins the moment food touches your mouth. Long before your immune system reacts, bacteria in your saliva and gut may already be shaping what happens next. For people with ...

Treatment with omalizumab offers modest protection from allergic reactions to individuals with multiple food allergies, and baseline immunoglobulin E (Ig E) levels are associated with success, based ...

Early introduction of allergens significantly reduces IgE-mediated allergies in infants, promoting oral tolerance. Historical guidelines recommended delaying allergen introduction, but recent research ...

Researchers have identified bacteria living in human saliva that can break down the two most dangerous peanut allergy proteins, reducing their ability to trigger life-threatening immune reactions. The ...